We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Foreign stocks · NASDAQ · Healthcare · Home healthcare services
Held by 1 funds1 open to buy1 AMCs
Last close (USD)14.23+0.95 (+7.15%)as of 4 Nov 2026
Funds that hold it1One fund per scheme
Held through a master fund10 buy the stock themselves
Largest weight in a single fund0.80%Of that fund's NAV
Median weight0.80%Half the funds hold more than this
What does AVAH do
Aveanna Healthcare Holdings, Inc.
Provides home nursing and health care for children and chronically ill patients in the US, with most revenue from public health insurance programmes such as Medicaid
Private Duty NursingHome Health & HospiceMedical Solutions (DME)Pediatric therapy
Where the revenue comes from, and how much is left as profit (FY2026)
For every 100 dollars of sales: cost of sales 67 · operating expenses 23 · tax and other items 1 · leaving 9 as net profit
Which funds let you invest in AVAH
Sorted by weight held, largest first
Investors in Thailand can buy AVAH through 1 mutual funds open to retail investors. Most of them (1 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds AVAH.
Showing 1 of 1 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
AVAH share price
0.00%
Price change over the selected periodN/A
50-day average
200-day average
Thai funds holding AVAH
1 funds · Highest 0.80% · Median 0.80%
How the weights are spread
Number of funds by weight range
1
0
0
0
0
0
< 1%1–3%3–5%5–8%8–12%12%+
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
How many funds each AMC holds it through
DAOLINV
How Thai money reaches AVAH
1 master funds
Master fund
Thai funds using this route
Master fund's AVAH weight
First Trust Small Cap Growth AlphaDEX® Fund
1
0.80%
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Financial statements: SEC EDGAR · Ratios: Market data · Revenue by business segment: SEC EDGAR · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
Valuation and key ratios
Aveanna Healthcare Holdings, Inc. · NASDAQ · Fiscal year ends in January
Market cap3.1B USD0.22 billion shares
P/E13.6xPrice ÷ FY2026 EPS 1.05
Forward P/E13.8xBased on forecast 12-month earnings
P/S1.1x
EV/EBITDA14.2x
Dividend yield0.00%0.00 USD per share a year
ROE634.7%Net profit ÷ shareholders' equity
Debt to equity (D/E)6.68xInterest-bearing debt
Beta2.01Against the S&P 500
Gross margin33.3%FY2026
Operating margin10.5%FY2026
Net margin9.2%FY2026
Price ratios use the latest close shown on this page · Forward P/E, P/S and EV/EBITDA from Market data · Beta from 5 years of monthly returns · Total dividends over the last 12 months
Company health made simple
From the FY2026 statements
Sales growth9.7%Steady growth
Yearly average over the last 4 years · Latest annual sales 2.4B USD
Profit from sales9%Moderate
For every 100 dollars of sales, about 9 dollars is left as net profit
Dividend0.00%No dividend
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
1-year share price+52.8%Up
Now 1.0% below its 1-year high
A rise or fall in the share price doesn't move a fund by the same amount — a fund is affected only in proportion to how much it holds
Financial statements
Revenue grows 9.7% a year on average · EPS grows N/A a year on average
Annual · last 5 fiscal years
Revenue and net profit
FY20221.7B USD−117.0M USD
FY20221.8B USD−662.0M USD
FY20231.9B USD−135.0M USD
FY20242.0B USD−11.0M USD
FY20262.4B USD225.0M USD
Total revenue
Net profit
Quarterly · last 5 quarters
Revenue and net profit
Q2 FY2026590.0M USD27.0M USD
Q3 FY2026622.0M USD14.0M USD
Q4 FY2026662.0M USD179.0M USD
Q1 FY2027648.0M USD42.0M USD
Q2 FY2027670.0M USD40.0M USD
Annual income statement, balance sheet and cash flow
Item (USD)
FY2022
FY2022
FY2023
FY2024
FY2026
Total revenue
1.7B USD
1.8B USD
1.9B USD
2.0B USD
2.4B USD
Gross profit
542.0M USD
553.0M USD
595.0M USD
636.0M USD
810.0M USD
Operating profit
Free cash flow = operating cash flow − capital expenditure · A cell showing N/A is an item the statement doesn't report, not a zero · Source: SEC EDGAR
Technical analysis
Closed at 14.23 USD on 4 Nov 2026
Daily trendClear uptrendScore 1.00 on a scale of −1 to +1 · 1254 bars
RSI(14)
69.2
ADX(14)
22.0
Position in the price range
97%
Weekly trendClear uptrendScore 0.50 on a scale of −1 to +1 · 262 bars
RSI(14)
71.5
ADX(14)
42.1
Position in the price range
98%
Monthly trendClear uptrendScore 0.50 on a scale of −1 to +1 · 61 bars
RSI(14)
72.9
ADX(14)
45.3
Position in the price range
99%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
13.27
13.28
Above
20 days
12.85
13.06
Above
50 days
13.11
12.61
Above
100 days
11.45
11.58
Above
200 days
Indicators (daily)
Indicator
Value
Signal
RSI(14)
69.22
Up
MACD(12,26)
0.23
Up
ADX(14)
22.05
Neutral
ATR(14) % of price
1.77
Neutral
Support and resistance (weekly pivots)
s312
s212
s1
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in AVAH, not the look-through weight · Past performance is not a guarantee of future performance